Lack of correlation of free deoxypyridinoline excretion with Taq1 restriction length polymorphisms in the vitamin D receptor gene in males

Clinica Chimica Acta

Volumn 272, Issue 2, 1998, Pages 149-157

  Rees, Gwen S ^b   Symes, Elizabeth K ^a   Nicholl, Claire G ^a   Legon, Stephen ^a   Chapman, Richard S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Bone resorption; Urinary free deoxypyridinoline; Vitamin D receptor alleles

Indexed keywords

DEOXYPYRIDINOLINE; VITAMIN D RECEPTOR;

ALLELE; ARTICLE; DNA POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; URINARY EXCRETION;

ADULT; AMINO ACIDS; BONE DENSITY; BONE RESORPTION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; TAQ POLYMERASE;

EID: 0032571749     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00016-3     Document Type: Article

References (33)

1. [1] Hansen MA, Kirsten O, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in post menopausal osteoporosis: 12 years study. Br Med J 1991;303:961-4.
2. [2] Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Ebert S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706-10.
3. [3] Dequeker J, Nijs N, Verstraeten A, Guesens P, Gevers G. Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone 1987;8:207-9.
4. [4] Moller M, Horsman A, Harvald B, Hauge M, Henningsen K, Nordin BEC. Metacarpal morphometry in monozygotic and dizygotic twins. Calcif Tissue Int 1978;25:197-201.
5. [5] Seeman E, Hopper JL, Bach LA et al. Reduced bone mass in daughters of women with oesteoporosis. New Engl J Med 1989;320:554-8.
6. [6] Garnero P, Arden IVK, Griffiths G, Delmas PD, Spector TD. Genetic influence on bone turnover in post menopausal twins. J Clin Endocrinol Metab 1996;81:140-6.
7. [7] Morrison NA, Qi JC, Tokita A, Kelly PJ et al. Prediction of bone density from vitamin D receptor alleles. Nature (Lond) 1994;367:284-7.
8. [8] Spector TD, Keen RW, Arden NK et al. Influence of vitamin D receptor genotype on bone mineral density in post menopausal women: a twin study in Britain. Br Med J 1995;310:1357-60.
9. [9] Fleet JC, Harris SS, Wood RV, Dawson-Hughes B. The Bsm1 vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995;10:985-90.
10. [10] Riggs BL, Nguyen TV, Melton III LJ et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995;10:991-6.
11. [11] Peacock M. Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res 1995;10:1294-7.
12. [12] Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density?. J Bone Miner Res 1996;11:1841-9.
13. [13] Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 1995;10:2017-22.
14. [14] Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980;66:878-83.
15. [15] Brown JP, Delmas PD, Malaval L, Edouard C, Chapnuy MC, Meunier PJ. Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984;1:1091-3.
16. [16] Lian J, Stewart C, Puchacz E, Mackowiak S et al. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 1989;86:1143-7.
17. [17] Kerner SA, Scott RA, Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA 1989;86:4455-9.
18. [18] Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 1992;89:6665-9.
19. [19] Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA. Genetic factors in bone turnover. J Clin Endocrinol Metab 1991;72:808-13.
20. [20] Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. Evaluation of urinary hydroxypyridinium crosslink measurements as résorption markers in metabolic bone disease. Eur J Clin Invest 1991;21:310-5.
21. [21] Eyre DR, Koob TL, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984;137:380-8.
22. [22] Robins SP, Duncan A. Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur. Biochim Biophys Acta 1987;914:233-9.
23. [23] Thompson PW, Spector TD, Edwards AC, James IT. Urinary deoxypyridinoline and serum osteocalcin as a measure of bone metabolism in early postmenopausal women: distribution and comparison with other measures. In: Christiansen C, Overgaard K, editors. Osteoporosis. Copenhagen: Osteoporosis, 1990:493-495.
24. [24] Baker AR, McDonnell DP, Hughes M et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988;85:3294-8.
25. [25] Sealey PG, Whittaker PA, Southern EM. Removal of repeated sequences from hybridisation probes. Nucleic Acids Res 1985;13:1906-22.
26. [26] Chasser AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Med J Clin Pathol 1961;35:83-8.
27. [27] Schlemmer A, Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C. Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol 1993;129:388-92.
28. [28] Schlemmer A, Hassager C, Delmas PD, Christiansen C. Urinaryexcretion of pyridinium crosslinks in healthy women; the long term effects of menopause and oestrogen/progesterone therapy. Clin Endocrinol 1994;40:777-82.
29. [29] Panteghini M, Pagani F. Biological variation in urinary excretion of pyridinium crosslinks: recommendations for the optimum specimen. Ann Clin Biochem 1996;33:36-42.
30. [30] Hustmeyer FG, Deluca HF, Peacock M. Apa1, Bsm1, EcoRV and Taq1 polymorphisms at the human vitamin D receptor gene locus in Caucasians, Blacks and Asians. . Hum Mol Genet 1993;2:487.
31. [31] Keen RW, Major PJ, Lanchbury JS, Spector TD. Vitamin-D-receptor-gene polymorphism and bone loss. Lancet 1995;345:990.
32. [32] Tokita A, Matsumoto H, Morrison NA et al. Vitamin D receptor alleles, bone density and turnover in premenopausal Japanese Women. J Bone Miner Res 1996;11:1003-9.
33. [33] Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-9.